Notice of Change of Location of Annual Meeting of Stockholders to be Held on June 23, 2020
June 05 2020 - 5:00PM
CymaBay Therapeutics, Inc. (Nasdaq: CBAY), a clinical-stage
biopharmaceutical company focused on developing therapies for liver
and other chronic diseases with high unmet need, today
announced that, due to public health and safety concerns
related to the COVID-19 global pandemic, recommendations and orders
from federal, state and local authorities, and to support the
health and well-being of its stockholders, employees and others,
CymaBay is changing its 2020 Annual Meeting of Stockholders (the
“Annual Meeting”) to a virtual-only format that will be held via
live audio webcast. The virtual Annual Meeting is expected to
provide stockholders with the same rights and opportunities to
participate as they would have at an in-person meeting.
The previously announced date and time of the
Annual Meeting, Tuesday, June 23, 2020, at 10:00 a.m. Pacific Time,
as disclosed in the previously distributed Notice of the Annual
Meeting and Definitive Proxy Statement, has not changed. Online
access to the Annual Meeting will begin at 9:45 a.m. Pacific Time.
Stockholders will not be able to attend the Annual Meeting in
person.
Attending the Virtual Meeting as a
Stockholder of RecordCymaBay’s stockholders of record as
of April 28, 2020 (the “Record Date”) can attend the Annual Meeting
by accessing the meeting center
at www.virtualshareholdermeeting.com/CBAY2020 and
entering the 16-digit control number on the proxy card or Notice of
Internet Availability of Proxy Materials previously received.
Instructions on how to connect to the Annual Meeting and
participate via the Internet, including how to demonstrate proof of
stock ownership, are posted at
http://www.virtualshareholdermeeting.com/CBAY2020.
If you do not have your 16-digit control number,
you will be able to access and listen to the Annual Meeting, but
you will not be able to vote your shares or submit questions during
the Annual Meeting. See caption below titled caption “Attending the
Annual Meeting as a Guest.”
Attending the Annual Meeting as a
Beneficial Owner Beneficial stockholders as of the Record
Date (i.e. shares held in “street name” through an intermediary,
such as a bank or broker), who want to be able attend the Annual
Meeting can attend using the 16-digit control number found on the
notice and instructions received from their broker or other
nominee.
Asking Questions If you are
attending the Annual Meeting as stockholder of record or beneficial
owner, questions can be submitted by accessing the meeting center
at http://www.virtualshareholdermeeting.com/CBAY2020, entering your
16-digit control number. Instructions on how to participate in the
Annual Meeting are posted at
http://www.virtualshareholdermeeting.com/CBAY2020.
Voting SharesStockholders of
record and beneficial owners will be able to vote their shares
electronically during the Annual Meeting by using the 16-digit
control number. Instructions on how to vote while participating in
the Annual Meeting live via the Internet are posted at
http://www.virtualshareholdermeeting.com/CBAY2020.
Whether or not stockholders plan to attend
virtually the Annual Meeting, CymaBay urges them to vote and submit
their proxy in advance of the Annual Meeting by one of the methods
described in the proxy materials for the Annual Meeting.
The proxy materials, including the proxy card and Notice of
Internet Availability of Proxy Materials, previously distributed
along with the definitive proxy statement will not be updated to
reflect the change in location and may continue to be used to vote
shares in connection with the Annual Meeting.
Attending the Annual Meeting as a
GuestGuests may enter the Annual Meeting in “listen-only”
mode by entering the Annual Meeting
at http://www.virtualshareholdermeeting.com/CBAY2020 and
entering the information requested in the “Guest Login” section.
Guests will not have the ability to vote or ask questions during
the Annual Meeting.
List of StockholdersA list of
stockholders entitled to vote at the Annual Meeting will be
available for examination for any purpose germane to the Annual
Meeting during normal business hours for ten days prior to the
Annual Meeting at our corporate headquarters. To the extent office
access is impracticable due to the recent COVID-19 pandemic, you
may email CymaBay at shareholders@cymabay.com to arrange for
alternative arrangements. The stockholder list will also be
available during the Annual Meeting at
http://www.virtualshareholdermeeting.com/CBAY2020. Instructions on
how stockholders of record can view the stockholder list during the
Annual Meeting are posted at
www.virtualshareholdermeeting.com/CBAY2020.
About CymaBay CymaBay
Therapeutics, Inc. is a clinical-stage biopharmaceutical company
focused on developing therapies for liver and other chronic
diseases with high unmet medical need.
For additional information about CymaBay visit
www.cymabay.com.
Contact:Sloane & CompanyDan
Zacchei / Joe Germani,
212-486-9500Dzacchei@sloanepr.com / JGermani@sloanepr.com
Cymabay Therapeutics (NASDAQ:CBAY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Cymabay Therapeutics (NASDAQ:CBAY)
Historical Stock Chart
From Apr 2023 to Apr 2024